A real advance in image-based PCa diagnosis was reached with the development of the 68Ga-labeled PSMA-HBED-CC compound (also named PSMA-11), which presents advantageous characteristics for imaging PCa metastases as a PET radiopharmaceutical [22]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.